Fig 7. Differential effects of FS on the intensity of pH3 immunostaining in the PrLCx and the ILCx.
(A) Representative high magnification images showing pH3 immunostaining in ILCx of RLA animals under basal conditions and after FS. Arrowheads indicate pH3-expressing neurons with different immunolabeling intensity (black arrowhead: higher intensity; white arrowhead: lower intensity). (B, C) Quantitative analysis of pH3-labeling intensity in PrLCx (B) and ILCx (C). PrLCx: RHA Bs = 0.06 ± 0.004; RLA Bs = 0.06 ± 0.004; RHA FS = 0.12 ± 0.005; RLA FS = 0.10 ± 0.009; two-way ANOVA: (line) F(1,18) = 4.93, p = 0.03$; (FS) F(1,18) = 70.41, p < 0.0001***; (line x FS interaction) F(1,18) = 3.48, p = 0.07; ILCx: RHA Bs = 0.07 ± 0.003; RLA Bs = 0.06 ± 0.003; RHA FS = 0.13 ± 0.003; RLA FS = 0.11 ± 0.002; two-way ANOVA: (line) F(1,18) = 11.85, p < 0.003$ $; (FS): F(1,18) = 154.81, p < 0.0001***; (line x FS interaction) F(1,18) = 1.26, n.s. Bonferroni post-hoc test FS p < 0.05§. Student’s t-test for independent samples: p < 0.05◊). (D-G) Quantitative analysis of pH3-labeling intensity distributions in the PrLCx (D, E) and the ILCx (F, G) of each experimental group. PrLCx χ2 test: RHA Bs > RLA Bs, p < 0.05#; RHA FS > RLA FS, p < 0.001###; ILCx χ2 test: RHA Bs > RLA Bs, p < 0.001###; RHA FS > RLA FS, p < 0.01##). Number of animals in each experimental group: RHA Bs, n = 6; RLA Bs, n = 6; RHA FS, n = 5; RLA FS, n = 5. Scale bar = 20 μm.